Perspective Therapeutics, Inc. (CATX)
(Real Time Quote from BATS)
$3.75 USD
-0.07 (-1.83%)
Updated Aug 7, 2025 09:58 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Perspective Therapeutics, Inc. has a market cap of $283.55M, which represents its share price of $3.82 multiplied by its outstanding shares number of 74.23M. As a small-cap company, CATX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CATX 3.75 -0.07(-1.83%)
Will CATX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CATX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CATX
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
CATX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?
Down -16.6% in 4 Weeks, Here's Why Perspective Therapeutics (CATX) Looks Ripe for a Turnaround
Is Perspective Therapeutics, Inc. (CATX) Outperforming Other Medical Stocks This Year?
Other News for CATX
Perspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter Therapy
Perspective Therapeutics Announces Acceptance of VMT-?-NET Data for Presentation at the ESMO ...
Trust healthcare analyst holds analyst/industry conference call
Perspective Therapeutics management to meet with Piper Sandler
Perspective Therapeutics management to meet with Piper Sandler